Cargando…
Treatment of Bilateral Retinal Angiomatous Proliferation with Anti-vascular Endothelial Growth Factor: 12-Month Outcome
PURPOSE: To evaluate the 12-month outcome of intravitreal anti-vascular endothelial growth factor therapy in eyes with bilateral retinal angiomatous proliferation (RAP). METHODS: This retrospective observational study included 38 eyes of 19 patients with stage 1 or 2 bilateral RAP at diagnosis. The...
Autores principales: | Kim, Jae Min, Kim, Jae Hui, Chang, Young Suk, Kim, Jong Woo, Kim, Chul Gu, Lee, Dong Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Ophthalmological Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469927/ https://www.ncbi.nlm.nih.gov/pubmed/28471100 http://dx.doi.org/10.3341/kjo.2016.0026 |
Ejemplares similares
-
Characteristic Findings of Optical Coherence Tomography in Retinal Angiomatous Proliferation
por: Lim, Eun-Hae, et al.
Publicado: (2013) -
Bilateral Retinal Angiomatous Proliferation in a Variant of Retinitis Pigmentosa
por: Aloe, G., et al.
Publicado: (2019) -
Retinal Angiomatous Proliferation and Intravitreal Bevacizumab Injection
por: Kang, Jae Hoon, et al.
Publicado: (2007) -
Incidence and risk factors of massive subretinal hemorrhage in retinal angiomatous proliferation
por: Lee, Jae Hyung, et al.
Publicado: (2017) -
Fundus autofluorescence of retinal angiomatous proliferation
por: Saito, Masaaki, et al.
Publicado: (2020)